← Back to Search

Home-Based e-Rehabilitation for Osteoarthritis (ReDI@Home Trial)

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have activity limitations because of joint pain
Must not have
Patients who are not eligible for TJA due to uncontrolled medical conditions (e.g., diabetes, hypertension) will be excluded due to safety concerns (i.e., undertaking exercise in their health state)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Awards & highlights

Summary

This trial will help to improve access to rehabilitation for rural residents with OA by examining the feasibility of home-based e-Rehabilitation delivered via smart phone.

Who is the study for?
This trial is for adults with moderate to advanced hip or knee osteoarthritis who live in rural areas, are not eligible for joint replacement within a year, and can use a smartphone or tablet. They should need guided exercise but be able to move around on their own, even if they need aids.Check my eligibility
What is being tested?
The study tests two home-based e-Rehabilitation programs delivered via smartphone for people with osteoarthritis. One program has low intensity (eRP-LO) and the other high intensity (eRP-HI), aiming to see which improves self-management and patient outcomes more effectively.See study design
What are the potential side effects?
Since this trial involves exercise and self-management strategies without medication, side effects may include muscle soreness or strain from physical activity. However, specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My joint pain limits my daily activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not eligible for joint surgery due to uncontrolled health issues like diabetes or high blood pressure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Patient Activation Measure from baseline to post intervention and 6-months and 12-months
Secondary outcome measures
Canadian Longitudinal Study of Aging
Change in 30-second Chair Stand test from baseline to post intervention and 6-months and 12-months
Change in Global Rating of Change from baseline to post intervention and 6-months and 12-months
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: eRP-LOw Intensity (eRP-LO)Experimental Treatment2 Interventions
an 8-week intervention that includes FOUR virtual visits with a physiotherapist
Group II: eRP-HIgh Intensity (eRP-HI)Experimental Treatment2 Interventions
an 8-week intervention that includes EIGHT virtual visits with a physiotherapist
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
progressive resistance exercise
2002
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
901 Previous Clinical Trials
387,438 Total Patients Enrolled
9 Trials studying Osteoarthritis
670 Patients Enrolled for Osteoarthritis

Media Library

Progressive Resistance Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05164575 — N/A
Osteoarthritis Research Study Groups: eRP-HIgh Intensity (eRP-HI), eRP-LOw Intensity (eRP-LO)
Osteoarthritis Clinical Trial 2023: Progressive Resistance Exercise Highlights & Side Effects. Trial Name: NCT05164575 — N/A
Progressive Resistance Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05164575 — N/A
~31 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top